Article Text

Download PDFPDF

P88 Cell free DNA bacterial sequences in patients with lupus nephritis differ from patients with IgA nephropathy and membranous nephropathy
  1. Bartosz Foroncewicz1,
  2. Krzysztof Mucha1,2,
  3. Arkadiusz Gładki2,
  4. Barbara Moszczuk1,
  5. Natalia Krata1,
  6. Marta Monticolo1,
  7. Urszula Zielenkiewicz2,
  8. Piotr Zielenkiewicz2 and
  9. Leszek Pączek1,2
  1. 1Dept. of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, Warsaw
  2. 2Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland


Background The circulating free DNA (cfDNA) originating mostly from the abnormal cell apoptosis, necrosis or netosis contains sequences of microorganisms encountered previously by the patients. Therefore, it may be a source of information about past infections and may become a tool to evaluate human microbiome in relation to specific diseases. The aim of the study was to identify bacterial sequences in cfDNA of patients with different types of glomerulopathies.

Methods Blood samples from 9 patients with lupus nephritis (LN), 5 with IgA nephropathy, 4 with membranous nephropathy and 3 healthy controls were collected once. cfDNA was isolated (QIAmp, Qiagen) and quantified (Thermo Fisher Scientific, Waltham). Sequencing libraries were constructed, and quality checked (KAPA-Roche, Basel). Samples were sequence d on NextSeq 550 (Illumina, San Diego), before a multi-step bioanalysis.

Results Bacterial sequences represented 0.031% of the cfDNA. The most frequent bacterial genera in the cfDNA of patients with glomerulopathies included: Esherichia, Streptococcus, Klebsiella, Brevundimonas and Moraxella and they varied between the studied patient groups. The cluster of four LN and one MN patients had distinctive bacterial cfDNA pattern which was observed on the species, family, order, class and phylum level.

Conclusions Bacterial sequences in cfDNA of patients with lupus nephritis differ from patients with IgA nephropathy and membranous nephropathy. Validation in a larger patient population is warranted.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.